tiprankstipranks

Individual - New Portfolio

2215F904

Individual
Individual Investor
Ranked #463,330 out of 769,291 TipRanks' Investors
Success Rate
49%
29 out of 59
profitable transactions
Average Return
-0.37%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 8.20%
6-Month Return▲ 7.42%
12-Month Return▲ 29.16%
YTD Return▲ 17.16%
Total Return▼ 43.46%

Best Trade

Opened at
Closed at
Gain▲ 333.95%

Bio

Performance

37.60%0-37.60%
▼ 12.40%
▼ 4.03%
▼ 5.43%
Apr 2024
▲ 11.46%
▲ 5.06%
▼ 1.61%
May 2024
▼ 2.25%
▲ 3.53%
▼ 4.13%
Jun 2024
▲ 25.72%
▲ 1.21%
▼ 3.58%
Jul 2024
▼ 4.22%
▲ 2.34%
▲ 1.12%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 5.43%
Sep 2024
▲ 5.70%
▼ 0.89%
▲ 7.08%
Oct 2024
▲ 37.60%
▲ 4.40%
▲ 2.75%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 5.43%
▲ 11.46%▲ 5.06%▼ 1.61%
▼ 2.25%▲ 3.53%▼ 4.13%
▲ 25.72%▲ 1.21%▼ 3.58%
▼ 4.22%▲ 2.34%▲ 1.12%
▲ 7.82%▲ 2.10%▲ 5.43%
▲ 5.70%▼ 0.89%▲ 7.08%
▲ 37.60%▲ 4.40%▲ 2.75%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Equitrans Midstream
▲ 92.89%
3
Close
Jul 22, 2024
Fusion Pharmaceuticals
▲ 333.95%
2
Close
Jun 03, 2024
Electrameccanica Vehicles
▼ 92.29%
2
Close
Mar 27, 2024
Xos
0.02%
▼ 60.62%
1
Buy
Mar 27, 2024
FedNat Holding
▼ 97.10%
3
Close
Nov 08, 2023
Zynerba Pharmaceuticals
▲ 154.40%
2
Close
Oct 10, 2023
Marvell
▲ 24.70%
3
Sell
Aug 13, 2023
Rithm Capital
10.21%
▲ 7.83%
3
Buy
Aug 11, 2023
Verizon
2.24%
▼ 14.25%
4
Buy
Aug 11, 2023
T. Rowe Price All-Cap Opportunities Fund
27.36%
▲ 50.35%
6
Buy
Aug 11, 2023
9 Meters Biopharma
0%
▼ 98.82%
4
Buy
Aug 11, 2023
BridgeBio Pharma
2.31%
▼ 25.50%
1
Buy
Aug 10, 2023
Royal Caribbean
16.65%
▲ 123.39%
1
Buy
Aug 10, 2023
UnitedHealth
11.64%
▲ 17.48%
1
Buy
Jul 31, 2023
Western Union
0.23%
▼ 38.52%
2
Buy
Jul 26, 2023
Quince Therapeutics
3.84%
▼ 63.94%
6
Buy
Jul 26, 2023
Alphabet Class A
▲ 14.71%
4
Sell
Jul 26, 2023
Honda Motor Company
1.31%
▲ 5.62%
2
Buy
Jul 26, 2023
Getty Realty
▲ 35.09%
2
Close
Jul 26, 2023
Eightco Holdings
0.01%
▼ 99.41%
5
Buy
Jul 26, 2023